Spots Global Cancer Trial Database for Eligard Observational Registry for Patients With Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Eligard Observational Registry for Patients With Prostate Cancer
Official Title: A Prospective, Single Product, Observational Registry Involving Patients Presenting With Locally Advanced or Metastatic Prostate Cancer Receiving Eligard as Androgen Deprivation Treatment.
Study ID: NCT00992251
Conditions
Interventions
Study Description
Brief Summary: The objective of this registry is to collect data on patient demographics, medical history, change in prostate, bone and overall health of the patients receiving androgen ablation treatment using Eligard. Data collected through this national registry program provides an opportunity to increase knowledge of efficacy and safety of the long term treatment with Eligard, provide a platform to better identify patient segments for the therapy with Eligard®. Furthermore registries are the only tools to accurately capture rare adverse events.
Detailed Description: 354 patients were enrolled in this study. Only 88 patients completed the study. For those patients completing the three years of data collection, 10% were considered Castrate Resistant and remained on Eligard®. For those patients not completing 3 years of follow-up, 8.8% were considered Castrate Resistant and did not continue in the study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Dr. George Vrabec, Abbotsford, British Columbia, Canada
Southern Interior Medical Research Corporation, Kelowna, British Columbia, Canada
Dr. Cal Andreou, Surrey, British Columbia, Canada
Dr. Nazif Omar, Surrey, British Columbia, Canada
Dr. Herman Kwan, Surrey, British Columbia, Canada
Dr. Joseph Zadra, Barrie, Ontario, Canada
Dr. Jonathan Giddens, Brampton, Ontario, Canada
Brantford Urology Research, Medical Arts Building, Brantford, Ontario, Canada
G. Kenneth Jansz Medicine Professional Corporation, Burlington, Ontario, Canada
Dr. Eric Hirshberg, Guelph, Ontario, Canada
Dr. Anil Dapoor, Hamilton, Ontario, Canada
Dr. Giovanni A. DiCostanzo, Markham, Ontario, Canada
Dr. Morrie Liquornik, Newmarket, Ontario, Canada
Dr. Roger Buckley, North York, Ontario, Canada
Dr. Stanley Flax, North York, Ontario, Canada
Dr. Jack Barkin, North York, Ontario, Canada
Dr. Richard Casey, Oakville, Ontario, Canada
Orillia Urology Associates, Orillia, Ontario, Canada
Kawartha Urology Associates, Peterborough, Ontario, Canada
Dr. Mohamed Elharram, Peterborough, Ontario, Canada
Dr. Emmanuel Abara, Richmond Hill, Ontario, Canada
Dr. Vinod Mathur, Sault Ste. Marie, Ontario, Canada
Dr. Edward Woods, Scarborough, Ontario, Canada
Dr. Bisshwajit Bora, Sudbury, Ontario, Canada
Dr. Nick Logarakis, Toronto, Ontario, Canada
Dr. Harold Kwok, Toronto, Ontario, Canada
Dr. Ashis Chawla, Toronto, Ontario, Canada
Dr. Jain Umesh, Toronto, Ontario, Canada
Dr. Louis-Rene Barrette, Chicoutimi, Quebec, Canada
Dr. Mahmoud Nachabe, Greenfield Park, Quebec, Canada
Polyclinique Med Concorde, Laval, Quebec, Canada
Dr. Thu Van Nguyen, Montreal, Quebec, Canada
Dr. Pierre Karakiewicz, Montreal, Quebec, Canada
Dr. John Vary, Rimouski, Quebec, Canada
Dr. Thierry Tremblay, Val-d'Or, Quebec, Canada
Westmount Med Bldg, Westmount, Quebec, Canada
Contact Details
Name: Hélène Grassin
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
